Repligen
RGEN
#2201
Rank
NZ$15.64 B
Marketcap
NZ$277.29
Share price
-0.45%
Change (1 day)
47.45%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): NZ$0.13 Billion

According to Repligen 's latest financial reports the company's current earnings are NZ$0.76 Billion. In 2025 the company made an earning of NZ$0.14 Billion, an increase over its 2024 earnings that were of -NZ$10.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.13 B-6.85%
2025 NZ$0.14 B-1430.84%
2024 -NZ$10.72 Million-113.01%
2023 NZ$82.33 M-78.01%
2022 NZ$0.37 B33.37%
2021 NZ$0.28 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$60.23 M25.93%
2018 NZ$47.83 M105.61%
2017 NZ$23.26 M-11.46%
2016 NZ$26.27 M14.91%
2015 NZ$22.86 M20.26%
2014 NZ$19.01 M-51.49%
2013 NZ$39.19 M90.98%
2012 NZ$20.52 M
2010 NZ$0.29 M-103.81%
2009 -NZ$7.8 Million-223.84%
2008 NZ$6.29 M
2006 -NZ$4.23 Million229.64%
2005 -NZ$1.29 Million-89.16%
2004 -NZ$11.84 Million-16.86%
2003 -NZ$14.24 Million88.72%
2002 -NZ$7.55 Million-27.88%
2001 -NZ$10.46 Million-1.74%
2000 -NZ$10.65 Million85.93%
1999 -NZ$5.73 Million159.16%
1998 -NZ$2.21 Million85.71%
1997 -NZ$1.19 Million-70.83%
1996 -NZ$4.08 Million-72.41%
1995 -NZ$14.79 Million-60.63%
1994 -NZ$37.56 Million45.39%
1993 -NZ$25.84 Million39.45%
1992 -NZ$18.53 Million-32.3%
1991 -NZ$27.37 Million6.62%
1990 -NZ$25.67 Million1577.78%
1989 -NZ$1.53 Million-57.14%
1988 -NZ$3.57 Million-362.5%
1987 NZ$1.35 M-130.77%
1986 -NZ$4.42 Million136.36%
1985 -NZ$1.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.99 B 13,468.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$12.61 B 9,408.92%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$19.45 B 14,569.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.30 B 12,195.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-241.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.11 Billion-182.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.35 B 923.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.26 B 100.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.65 B 394.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$0.29 Billion-311.94%๐Ÿ‡บ๐Ÿ‡ธ USA